Oct 15, 2026 08:30AM
Oct 1, 2026 09:15AM
Oct 1, 2026 09:15AM
Oct 1, 2026 08:56AM
Oct 1, 2026 08:56AM
Aug 12, 2026 07:30AM
Jul 29, 2026 08:30AM FDA accepts PolyPid's D-PLEX100 NDA with priority review
Jul 29, 2026 08:30AM
Jul 22, 2026 06:53AM
Jul 21, 2026 07:30AM
Jul 21, 2026 07:30AM
Jul 21, 2026 07:30AM
Jun 1, 2026 08:32AM
Jun 1, 2026 08:30AM PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
May 13, 2026 07:30AM
Apr 28, 2026 08:30AM
Apr 28, 2026 08:30AM
Mar 31, 2026 08:30AM
Mar 31, 2026 08:30AM
Mar 17, 2026 08:30AM
Mar 17, 2026 08:30AM PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
Feb 11, 2026 07:31AM
Feb 11, 2026 07:30AM
Dec 3, 2025 08:32AM
Dec 3, 2025 08:30AM
Nov 25, 2025 08:30AM
Nov 12, 2025 07:30AM
Nov 6, 2025 08:30AM PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
Nov 6, 2025 08:30AM
Sep 16, 2025 08:33AM
Sep 16, 2025 08:30AM
Aug 13, 2025 07:30AM
Jun 17, 2025 04:08AM
Jun 16, 2025 07:20PM
Jun 9, 2025 10:13AM PolyPid (PYPD) shares surge on successful D-PLEX100 trial results
May 14, 2025 07:00AM
Apr 14, 2025 06:54AM
Dec 26, 2024 06:35AM
Dec 23, 2024 07:22PM
Nov 13, 2024 07:00AM
Oct 2, 2024 06:47AM
Jun 10, 2024 07:00AM PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
Aug 9, 2023 07:00AM
Jun 29, 2023 08:00AM
Jun 22, 2023 07:00AM
May 22, 2023 09:01AM
May 22, 2023 09:00AM
May 10, 2023 07:00AM
Feb 8, 2023 07:00AM PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Jan 24, 2023 07:05AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All